Literature DB >> 24499799

Apico-basal polarity complex and cancer.

Mohammed Khursheed1, Murali Dharan Bashyam.   

Abstract

Apico-basal polarity is a cardinal molecular feature of adult eukaryotic epithelial cells and appears to be involved in several key cellular processes including polarized cell migration and maintenance of tissue architecture. Epithelial cell polarity is maintained by three well-conserved polarity complexes, namely, PAR, Crumbs and SCRIB. The location and interaction between the components of these complexes defines distinct structural domains of epithelial cells. Establishment and maintenance of apico-basal polarity is regulated through various conserved cell signalling pathways including TGF beta, Integrin and WNT signalling. Loss of cell polarity is a hallmark for carcinoma, and its underlying molecular mechanism is beginning to emerge from studies on model organisms and cancer cell lines. Moreover, deregulated expression of apico-basal polarity complex components has been reported in human tumours. In this review, we provide an overview of the apico-basal polarity complexes and their regulation, their role in cell migration, and finally their involvement in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24499799     DOI: 10.1007/s12038-013-9410-z

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  105 in total

Review 1.  Regulation of Par6 by extracellular signals.

Authors:  Rohit Bose; Jeffrey L Wrana
Journal:  Curr Opin Cell Biol       Date:  2006-02-20       Impact factor: 8.382

Review 2.  Epithelial cell-cell junctions and plasma membrane domains.

Authors:  Ben N G Giepmans; Sven C D van Ijzendoorn
Journal:  Biochim Biophys Acta       Date:  2008-07-28

Review 3.  Molecular genetics of asymmetric cleavage in the early Caenorhabditis elegans embryo.

Authors:  S Guo; K J Kemphues
Journal:  Curr Opin Genet Dev       Date:  1996-08       Impact factor: 5.578

4.  SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasia.

Authors:  Helen B Pearson; Pedro A Perez-Mancera; Lukas E Dow; Andrew Ryan; Pierre Tennstedt; Debora Bogani; Imogen Elsum; Andy Greenfield; David A Tuveson; Ronald Simon; Patrick O Humbert
Journal:  J Clin Invest       Date:  2011-10-03       Impact factor: 14.808

5.  PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6.

Authors:  Carina H Storrs; Saul J Silverstein
Journal:  J Virol       Date:  2007-02-07       Impact factor: 5.103

6.  The polarity protein Par6 induces cell proliferation and is overexpressed in breast cancer.

Authors:  Marissa E Nolan; Victoria Aranda; Sangjun Lee; Balasubramanian Lakshmi; Srinjan Basu; D Craig Allred; Senthil K Muthuswamy
Journal:  Cancer Res       Date:  2008-10-15       Impact factor: 12.701

7.  Asymmetrically distributed PAR-3 protein contributes to cell polarity and spindle alignment in early C. elegans embryos.

Authors:  B Etemad-Moghadam; S Guo; K J Kemphues
Journal:  Cell       Date:  1995-12-01       Impact factor: 41.582

8.  The overexpression and altered localization of the atypical protein kinase C lambda/iota in breast cancer correlates with the pathologic type of these tumors.

Authors:  Yasuyuki Kojima; Kazunori Akimoto; Yoji Nagashima; Hitoshi Ishiguro; Sumiko Shirai; Takashi Chishima; Yasushi Ichikawa; Takashi Ishikawa; Takeshi Sasaki; Yoshinobu Kubota; Yoshiaki Inayama; Ichiro Aoki; Shigeo Ohno; Hiroshi Shimada
Journal:  Hum Pathol       Date:  2008-06       Impact factor: 3.466

9.  The C. elegans par-4 gene encodes a putative serine-threonine kinase required for establishing embryonic asymmetry.

Authors:  J L Watts; D G Morton; J Bestman; K J Kemphues
Journal:  Development       Date:  2000-04       Impact factor: 6.868

10.  The transcription factor ZEB1 (deltaEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity.

Authors:  K Aigner; B Dampier; L Descovich; M Mikula; A Sultan; M Schreiber; W Mikulits; T Brabletz; D Strand; P Obrist; W Sommergruber; N Schweifer; A Wernitznig; H Beug; R Foisner; A Eger
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

View more
  7 in total

1.  Spatial control of active CDC-42 during collective migration of hypodermal cells in Caenorhabditis elegans.

Authors:  Marie-Hélène Ouellette; Emmanuel Martin; Germain Lacoste-Caron; Karim Hamiche; Sarah Jenna
Journal:  J Mol Cell Biol       Date:  2015-11-16       Impact factor: 6.216

Review 2.  A family affair: A Ral-exocyst-centered network links Ras, Rac, Rho signaling to control cell migration.

Authors:  Giulia Zago; Marco Biondini; Jacques Camonis; Maria Carla Parrini
Journal:  Small GTPases       Date:  2017-05-12

Review 3.  Orchestration of tissue-scale mechanics and fate decisions by polarity signalling.

Authors:  Martim Dias Gomes; Sandra Iden
Journal:  EMBO J       Date:  2021-05-17       Impact factor: 11.598

Review 4.  Cell polarity signaling in the plasticity of cancer cell invasiveness.

Authors:  Aneta Gandalovičová; Tomáš Vomastek; Daniel Rosel; Jan Brábek
Journal:  Oncotarget       Date:  2016-05-03

Review 5.  The role of the oncogenic Rab35 in cancer invasion, metastasis, and immune evasion, especially in leukemia.

Authors:  Fabian R Villagomez; Oscar Medina-Contreras; Jorge Francisco Cerna-Cortes; Genaro Patino-Lopez
Journal:  Small GTPases       Date:  2018-05-28

6.  Phosphorylated Protein Kinase C (Zeta/Lambda) Expression in Colorectal Adenocarcinoma and Its Correlation with Clinicopathologic Characteristics and Prognosis.

Authors:  Min-Kyung Yeo; Ji Yeon Kim; In-Ock Seong; Jin-Man Kim; Kyung-Hee Kim
Journal:  J Cancer       Date:  2017-09-20       Impact factor: 4.207

7.  Expression and role of hScrib in endometrium, endometriosis, and endometrial adenocarcinoma.

Authors:  Zhuo Ouyang; Minxiu Chen; Jinping Sun; Jianjun Zhai
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.